Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 1 1

Status

Completed 2

Sponsor Class

NIH 2

Study Type

Interventional 2

Sponsor

Cancer Type

Sarcoma 2Lymphoid 2

Conditions

Lymphoma 51Lymphoma, Follicular 36Leukemia, Lymphocytic, Chronic, B-Cell 30Precursor Cell Lymphoblastic Leukemia-Lymphoma 29Lymphoma, Non-Hodgkin 29Lymphoma, Large B-Cell, Diffuse 25Lymphoma, Mantle-Cell 23Leukemia 23Lymphoma, Large-Cell, Immunoblastic 20Hodgkin Disease 18Burkitt Lymphoma 18Lymphoma, B-Cell, Marginal Zone 17Leukemia, Myeloid, Acute 15Myelodysplastic Syndromes 12Multiple Myeloma 12Neoplasms, Plasma Cell 9Leukemia, Myeloid, Accelerated Phase 9Myeloproliferative Disorders 8Leukemia, Myeloid, Chronic-Phase 8Congenital Abnormalities 8Waldenstrom Macroglobulinemia 7Recurrence 7Blast Crisis 7Lymphoma, T-Cell, Cutaneous 6Primary Myelofibrosis 5Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 5Dendritic Cell Sarcoma, Interdigitating 5Sezary Syndrome 4Mycosis Fungoides 4Lymphoma, Large-Cell, Anaplastic 4

Interventions

Cyclophosphamide 12Vincristine 10Doxorubicin 10Etoposide 8Rituximab 6Prednisone 6Cytarabine 6Dexamethasone 5Bleomycin 5Zidovudine 4Methotrexate 4Leucovorin 4Filgrastim 4Peripheral Blood Stem Cell Transplantation 3sargramostim 2fludarabine phosphate 2fludarabine 2Whole-Body Irradiation 2Vinblastine 2Polymerase Chain Reaction 2Melphalan 2Dacarbazine 2Carmustine 2Antiretroviral Therapy, Highly Active 2Allopurinol 2prednylidene 1pembrolizumab 1liposomal doxorubicin 1ibrutinib 1efavirenz 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
HIV Infections × sargramostim × Lymphoid × Clear all
NCT00000658 2021-11-03

A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 3 Completed
250 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, HIV Infections

NCT00000689 2021-11-02

Phase I Trial of mBACOD and Granulocyte-Macrophage Colony-Stimulating Factor (GM-CSF) in AIDS-Associated Large Cell, Immunoblastic, and Small Non-cleaved Lymphoma

National Institute of Allergy and Infectious Diseases (NIAID)

Phase 1 Completed
18 enrolled
Lymphoid

Acquired Immunodeficiency Syndrome, Lymphoma, Non-Hodgkin, Nervous System Neoplasms, HIV Infections

Data powered by HemOnc (CC BY 4.0) Colophon âš¡